China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Significance of TP53 Mutations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133404
Registration Time: 2026/09/25
Type: Observational study
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344200
Published by HT Digital Content Services with permission from Health Daily Digest....